View article

Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events

Authors

MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, CM Ballantyne, R Somaratne, J Legg, SM Wasserman, R Scott, MJ Koren, EA Stein

Publication date

2015/4/16

Journal

N Engl J Med

Volume

372

Issue

16

Pages

1500-1509

Total citations

201420152016201720182019202020212022202320242 49 107 92 54 43 36 39 15 14 6

Scholar articles

Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events

MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal… - N Engl J Med, 2015

Cited by 469 Related articles